speb/financial-data huggingface dataset:
MDCX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 8076732.00
MDCX income_statement (annual, 2023-12-31) — Other Gand A: 2222918.00
MDCX income_statement (annual, 2023-12-31) — Other Income Expense: -2071580.00
MDCX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 584820.00
MDCX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -3271462.00
MDCX income_statement (annual, 2023-12-31) — Other Special Charges: 2071580.00
MDCX balance_sheet (annual, 2023-12-31) — Payables: 376792.00
MDCX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 753843.00
MDCX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 27766.00
MDCX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 173719.00
MDCX income_statement (annual, 2023-12-31) — Pretax Income: -5314765.00
MDCX income_statement (annual, 2023-12-31) — Research And Development: 193578.00
MDCX balance_sheet (annual, 2023-12-31) — Retained Earnings: -17748387.00
MDCX income_statement (annual, 2023-12-31) — Salaries And Wages: 241869.00
MDCX income_statement (annual, 2023-12-31) — Selling General And Administration: 2464787.00
MDCX balance_sheet (annual, 2023-12-31) — Share Issued: 8076732.00
MDCX cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
MDCX income_statement (annual, 2023-12-31) — Special Income Charges: -2071580.00
MDCX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 98585.00
MDCX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1111448.00
MDCX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1111448.00
MDCX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MDCX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
MDCX balance_sheet (annual, 2023-12-31) — Total Assets: 1893057.00
MDCX balance_sheet (annual, 2023-12-31) — Total Capitalization: 1111448.00
MDCX balance_sheet (annual, 2023-12-31) — Total Debt: 0.00
MDCX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1111448.00
MDCX income_statement (annual, 2023-12-31) — Total Expenses: 2658365.00
MDCX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 781609.00
MDCX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 0.00
MDCX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MDCX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -4729945.00
MDCX income_statement (annual, 2023-12-31) — Total Other Finance Cost: 584820.00
MDCX income_statement (annual, 2023-12-31) — Total Unusual Items: -2071580.00
MDCX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2071580.00
MDCX balance_sheet (annual, 2023-12-31) — Working Capital: 1111448.00
MDCX balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -78395.00
MDCX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 9514738.00
MDCX income_statement (quarterly, 2024-09-30) — Basic EPS: -0.24
MDCX balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 356784.00
MDCX cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: 0.00
MDCX cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: -403328.00
MDCX cash_flow (quarterly, 2024-09-30) — Depreciation: 26322.00
MDCX cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 26322.00
MDCX income_statement (quarterly, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 26322.00
MDCX cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 26322.00
MDCX income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 26322.00
MDCX income_statement (quarterly, 2024-09-30) — Depreciation Income Statement: 26322.00
MDCX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 9514738.00
MDCX income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.24
MDCX income_statement (quarterly, 2024-09-30) — Insurance And Claims: 157018.00
MDCX income_statement (quarterly, 2024-09-30) — Interest Expense: 8983.00
MDCX income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 8983.00
MDCX income_statement (quarterly, 2024-09-30) — Interest Income: 55514.00
MDCX income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 55514.00
MDCX cash_flow (quarterly, 2024-09-30) — Interest Paid Cff: 0.00
MDCX cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
MDCX cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
MDCX cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
MDCX balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
MDCX income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 26322.00
MDCX income_statement (quarterly, 2024-09-30) — Salaries And Wages: 279358.00
MDCX income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
MDCX income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
MDCX income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MDCX income_statement (annual, 2024-12-31) — +Operating Expense: 11180902.00
MDCX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Accounts Payable: 1284612.00
MDCX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1520412.00
MDCX income_statement (annual, 2024-12-31) — Basic Average Shares: 9619184.00
MDCX income_statement (annual, 2024-12-31) — Basic EPS: -1.16
MDCX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1719338.00
MDCX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 322268.00
MDCX balance_sheet (annual, 2024-12-31) — Capital Stock: 30518195.00
MDCX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 4164323.00
MDCX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 4164323.00
MDCX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 12692216.00
MDCX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MDCX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -10247231.00
MDCX cash_flow (annual, 2024-12-31) — Change In Account Payable: 808745.00
MDCX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 358018.00
MDCX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -70080.00
MDCX cash_flow (annual, 2024-12-31) — Change In Payable: 785254.00
MDCX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1143272.00
MDCX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1040265.00
MDCX cash_flow (annual, 2024-12-31) — Change In Working Capital: 32927.00
MDCX cash_flow (annual, 2024-12-31) — Changes In Cash: 2444985.00
MDCX balance_sheet (annual, 2024-12-31) — Common Stock: 30518195.00
MDCX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3134704.00
MDCX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 7519716.00
MDCX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 621846.00
MDCX balance_sheet (annual, 2024-12-31) — Current Assets: 5378307.00
MDCX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 116323.00
MDCX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 116323.00
MDCX balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 0.00
MDCX balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Current Liabilities: 2306229.00
MDCX balance_sheet (annual, 2024-12-31) — Current Notes Payable: 0.00
MDCX balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 0.00
MDCX income_statement (annual, 2024-12-31) — Diluted Average Shares: 9619184.00
MDCX income_statement (annual, 2024-12-31) — Diluted EPS: -1.16
MDCX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -11155516.00
MDCX balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 142459.00
MDCX income_statement (annual, 2024-12-31) — EBIT: -11180902.00
MDCX income_statement (annual, 2024-12-31) — EBITDA: -11180902.00
MDCX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
MDCX cash_flow (annual, 2024-12-31) — End Cash Position: 4164323.00
MDCX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 12692216.00
MDCX cash_flow (annual, 2024-12-31) — Free Cash Flow: -10247231.00
MDCX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 238517.00
MDCX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
MDCX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
MDCX income_statement (annual, 2024-12-31) — General And Administrative Expense: 7653116.00
MDCX balance_sheet (annual, 2024-12-31) — Gross PPE: 268571.00
MDCX income_statement (annual, 2024-12-31) — Interest Expense: 902362.00
MDCX income_statement (quarterly, 2024-12-31) — Interest Expense: 796110.00
MDCX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 902362.00
MDCX income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 796110.00
MDCX income_statement (annual, 2024-12-31) — Interest Income: 104411.00
MDCX income_statement (quarterly, 2024-12-31) — Interest Income: 48897.00
MDCX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 104411.00
MDCX income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 48897.00
MDCX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 40563.00
MDCX balance_sheet (annual, 2024-12-31) — Invested Capital: 3134704.00
MDCX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
MDCX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 7519716.00
MDCX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 5172500.00
MDCX cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 205945.00
MDCX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 205945.00
MDCX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 5172500.00
MDCX cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
MDCX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
MDCX balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
MDCX income_statement (annual, 2024-12-31) — Minority Interests: 0.00
MDCX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
MDCX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 7519716.00
MDCX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MDCX income_statement (annual, 2024-12-31) — Net Income: -11155516.00
MDCX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -11155516.00
MDCX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -11155516.00
MDCX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -11155516.00
MDCX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -11155516.00
MDCX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -11155516.00
MDCX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -11155516.00
MDCX income_statement (annual, 2024-12-31) — Net Interest Income: 25386.00
MDCX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 5172500.00
MDCX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 5172500.00
MDCX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 25386.00
MDCX balance_sheet (annual, 2024-12-31) — Net PPE: 268571.00
MDCX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 3134704.00
MDCX income_statement (annual, 2024-12-31) — Normalized EBITDA: -11180902.00
MDCX income_statement (annual, 2024-12-31) — Normalized Income: -11155516.00
MDCX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -10247231.00
MDCX income_statement (annual, 2024-12-31) — Operating Income: -11180902.00
MDCX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 11816721.00
MDCX income_statement (annual, 2024-12-31) — Other Gand A: 7653116.00
MDCX income_statement (annual, 2024-12-31) — Other Income Expense: 238517.00
MDCX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 162239.00
MDCX balance_sheet (annual, 2024-12-31) — Other Properties: 268571.00
MDCX balance_sheet (annual, 2024-12-31) — Payables: 1427071.00
MDCX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2048917.00
MDCX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 140989.00
MDCX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1213984.00
MDCX income_statement (annual, 2024-12-31) — Pretax Income: -11155516.00
MDCX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
MDCX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
MDCX cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
MDCX income_statement (annual, 2024-12-31) — Research And Development: 3527786.00
MDCX balance_sheet (annual, 2024-12-31) — Retained Earnings: -28903903.00
MDCX income_statement (annual, 2024-12-31) — Salaries And Wages: 1850103.00
MDCX income_statement (quarterly, 2024-12-31) — Salaries And Wages: 449757.00
MDCX income_statement (annual, 2024-12-31) — Selling General And Administration: 7653116.00
MDCX balance_sheet (annual, 2024-12-31) — Share Issued: 11816721.00
MDCX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
MDCX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 713119.00
MDCX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3134704.00
MDCX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3134704.00
MDCX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MDCX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Total Assets: 5646878.00
MDCX balance_sheet (annual, 2024-12-31) — Total Capitalization: 3134704.00
MDCX balance_sheet (annual, 2024-12-31) — Total Debt: 322268.00
MDCX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3134704.00
MDCX income_statement (annual, 2024-12-31) — Total Expenses: 11180902.00
MDCX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2512174.00
MDCX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 268571.00
MDCX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 205945.00
MDCX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -11180902.00
MDCX income_statement (annual, 2024-12-31) — Total Other Finance Cost: -25386.00
MDCX income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
MDCX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MDCX balance_sheet (annual, 2024-12-31) — Working Capital: 3072078.00
MDCX income_statement (quarterly, 2025-03-31) — +Operating Expense: 5126274.00
MDCX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
MDCX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2035364.00
MDCX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3245163.00
MDCX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 12240437.00
MDCX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.42
MDCX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4164323.00
MDCX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 294693.00
MDCX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 32908702.00
MDCX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3982430.00
MDCX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3982430.00
MDCX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3759101.00
MDCX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3940994.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 655634.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 299203.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -27575.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Payable: 631390.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 930593.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 122639.00
MDCX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1025657.00
MDCX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -181893.00
MDCX balance_sheet (quarterly, 2025-03-31) — Common Stock: 32908702.00
MDCX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2147554.00
MDCX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 3784101.00
MDCX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 972339.00
MDCX balance_sheet (quarterly, 2025-03-31) — Current Assets: 5087775.00
MDCX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 120296.00
MDCX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 120296.00
MDCX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3335915.00
MDCX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 12240437.00
MDCX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.42
MDCX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -5102408.00
MDCX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 118215.00
MDCX income_statement (quarterly, 2025-03-31) — EBIT: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — EBITDA: -5102408.00
MDCX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
MDCX cash_flow (quarterly, 2025-03-31) — End Cash Position: 3982430.00
MDCX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3759101.00
MDCX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3940994.00
MDCX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3120060.00
MDCX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 245091.00
MDCX income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Interest Income: 23866.00
MDCX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 23866.00
MDCX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
MDCX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2147554.00
MDCX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 3784101.00
MDCX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 174397.00
MDCX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 174397.00
MDCX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
MDCX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 3784101.00
MDCX income_statement (quarterly, 2025-03-31) — Net Income: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -5102408.00
MDCX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Net Interest Income: 23866.00
MDCX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
MDCX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 23866.00
MDCX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -25000.00
MDCX balance_sheet (quarterly, 2025-03-31) — Net PPE: 245091.00
MDCX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2147554.00
MDCX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 325000.00
MDCX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -5102408.00
MDCX income_statement (quarterly, 2025-03-31) — Normalized Income: -5102408.00
MDCX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3940994.00
MDCX income_statement (quarterly, 2025-03-31) — Operating Income: -5126274.00
MDCX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
MDCX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 13417561.00
MDCX income_statement (quarterly, 2025-03-31) — Other Gand A: 3120060.00
MDCX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 23480.00
MDCX balance_sheet (quarterly, 2025-03-31) — Other Properties: 245091.00
MDCX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 14000.00
MDCX balance_sheet (quarterly, 2025-03-31) — Payables: 2153579.00
MDCX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3125918.00
MDCX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 89701.00
MDCX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1091345.00
MDCX income_statement (quarterly, 2025-03-31) — Pretax Income: -5102408.00
MDCX balance_sheet (quarterly, 2025-03-31) — Receivables: 14000.00
MDCX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Research And Development: 2006214.00
MDCX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -34006311.00
MDCX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 469794.00
MDCX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3120060.00
MDCX balance_sheet (quarterly, 2025-03-31) — Share Issued: 13417561.00
MDCX income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MDCX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 112277.00
MDCX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2147554.00
MDCX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2147554.00
MDCX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Assets: 5657866.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2147554.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Debt: 294693.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2147554.00
MDCX income_statement (quarterly, 2025-03-31) — Total Expenses: 5126274.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3510312.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 570091.00
MDCX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 174397.00
MDCX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -5126274.00
MDCX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MDCX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MDCX balance_sheet (quarterly, 2025-03-31) — Working Capital: 1751860.00
MDCX income_statement (quarterly, 2025-06-30) — +Operating Expense: 6016088.00
MDCX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
MDCX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1770178.00
MDCX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5597106.00
MDCX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 14284261.00
MDCX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.43
MDCX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3982430.00
MDCX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 266155.00
MDCX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 37833999.00
MDCX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 9669546.00
MDCX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 9669546.00
MDCX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 11155947.00
MDCX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -5468831.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -250964.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 766272.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -28538.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Payable: -247906.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 518366.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -235840.00
MDCX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 253988.00
MDCX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 5687116.00
MDCX balance_sheet (quarterly, 2025-06-30) — Common Stock: 37833999.00
MDCX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3248710.00
MDCX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 6005914.00
MDCX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1407018.00
MDCX balance_sheet (quarterly, 2025-06-30) — Current Assets: 10996731.00
MDCX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 124402.00
MDCX balance_sheet (quarterly, 2025-06-30) — Current Debt: 4700000.00
MDCX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4824402.00
MDCX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 8544165.00
MDCX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 14284261.00
MDCX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.43
MDCX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -6176084.00
MDCX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 121273.00
MDCX income_statement (quarterly, 2025-06-30) — EBIT: -6016088.00
MDCX income_statement (quarterly, 2025-06-30) — EBITDA: -6016088.00
MDCX cash_flow (quarterly, 2025-06-30) — End Cash Position: 9669546.00
MDCX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 11155947.00
MDCX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -5468831.00
MDCX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4576524.00
MDCX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 220999.00
MDCX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 7948710.00
MDCX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 6005914.00
MDCX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 141753.00
MDCX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 141753.00
MDCX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -54582.00
MDCX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 6005914.00
MDCX income_statement (quarterly, 2025-06-30) — Net Income: -6176084.00
MDCX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -6176084.00
MDCX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -6176084.00
MDCX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -6176084.00
MDCX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -6176084.00
MDCX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -6176084.00
MDCX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -6176084.00
MDCX income_statement (quarterly, 2025-06-30) — Net Interest Income: 40004.00
MDCX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 4445418.00
MDCX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 4445418.00
MDCX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 40004.00
MDCX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -272783.00
MDCX balance_sheet (quarterly, 2025-06-30) — Net PPE: 220999.00
MDCX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3248710.00
MDCX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 716898.00
MDCX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -6016088.00
MDCX income_statement (quarterly, 2025-06-30) — Normalized Income: -6176084.00
MDCX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -5468831.00
MDCX income_statement (quarterly, 2025-06-30) — Operating Income: -6016088.00
MDCX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
MDCX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 15936266.00
MDCX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 375810.00
MDCX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 4700000.00
MDCX income_statement (quarterly, 2025-06-30) — Other Gand A: 3667925.00
MDCX income_statement (quarterly, 2025-06-30) — Other Income Expense: -200000.00
MDCX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 335817.00
MDCX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -200000.00
MDCX balance_sheet (quarterly, 2025-06-30) — Other Properties: 220999.00
MDCX balance_sheet (quarterly, 2025-06-30) — Payables: 1891451.00
MDCX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3298469.00
MDCX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 421294.00
MDCX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 951375.00
MDCX income_statement (quarterly, 2025-06-30) — Pretax Income: -6176084.00
MDCX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -54582.00
MDCX income_statement (quarterly, 2025-06-30) — Research And Development: 1439564.00
MDCX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -40182395.00
MDCX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 908599.00
MDCX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4576524.00
MDCX balance_sheet (quarterly, 2025-06-30) — Share Issued: 15936266.00
MDCX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 117448.00
MDCX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3248710.00
MDCX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3248710.00
MDCX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MDCX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Assets: 11934628.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3248710.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Debt: 4966155.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3248710.00
MDCX income_statement (quarterly, 2025-06-30) — Total Expenses: 6016088.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8685918.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 937897.00
MDCX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 141753.00
MDCX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -6016088.00
MDCX income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -40004.00
MDCX balance_sheet (quarterly, 2025-06-30) — Working Capital: 2452566.00
MDCX income_statement (quarterly, 2025-09-30) — +Operating Expense: 15426340.00
MDCX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
MDCX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2027509.00
MDCX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 6449863.00
MDCX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 18631668.00
MDCX income_statement (quarterly, 2025-09-30) — Basic EPS: -1.12
MDCX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 9669546.00
MDCX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 236258.00
MDCX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 48792965.00
MDCX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 8662091.00
MDCX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8662091.00
MDCX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 10371267.00
MDCX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -6757829.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -784703.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -954308.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -50058.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Payable: -762896.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1717204.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 430723.00
MDCX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1336539.00
MDCX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1005714.00
MDCX balance_sheet (quarterly, 2025-09-30) — Common Stock: 48792965.00
MDCX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -910126.00
MDCX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 5097005.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1263127.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Assets: 9781412.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 141070.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Debt: 6785812.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 6926882.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10657901.00
MDCX balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 6785812.00
MDCX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 18631668.00
MDCX income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.12
MDCX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -15981312.00
MDCX balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 143080.00
MDCX income_statement (quarterly, 2025-09-30) — EBIT: -15426340.00
MDCX income_statement (quarterly, 2025-09-30) — EBITDA: -15426340.00
MDCX cash_flow (quarterly, 2025-09-30) — End Cash Position: 8662091.00
MDCX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 10371267.00
MDCX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -6757829.00
MDCX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 10676.00
MDCX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5024082.00
MDCX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 196249.00
MDCX income_statement (quarterly, 2025-09-30) — Interest Income: 11572.00
MDCX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 11572.00
MDCX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5905148.00
MDCX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 5097005.00
MDCX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 7366293.00
MDCX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 95188.00
MDCX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 29462.00
MDCX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 124650.00
MDCX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 7366293.00
MDCX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -5719853.00
MDCX balance_sheet (quarterly, 2025-09-30) — Minority Interest: 105236.00
MDCX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 5097005.00
MDCX income_statement (quarterly, 2025-09-30) — Net Income: -15981312.00
MDCX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -15981312.00
MDCX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -15981312.00
MDCX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -15981312.00
MDCX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -15981312.00
MDCX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -15981312.00
MDCX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -15981312.00
MDCX income_statement (quarterly, 2025-09-30) — Net Interest Income: 11572.00
MDCX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 1646440.00
MDCX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 1646440.00
MDCX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 11572.00
MDCX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -286578.00
MDCX balance_sheet (quarterly, 2025-09-30) — Net PPE: 196249.00
MDCX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -910126.00
MDCX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -15243619.00
MDCX income_statement (quarterly, 2025-09-30) — Normalized Income: -15798591.00
MDCX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -6757829.00
MDCX income_statement (quarterly, 2025-09-30) — Operating Income: -15426340.00
MDCX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
MDCX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20971122.00
MDCX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 390942.00
MDCX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 10676.00
MDCX income_statement (quarterly, 2025-09-30) — Other Gand A: 3599867.00
MDCX income_statement (quarterly, 2025-09-30) — Other Income Expense: -566544.00
MDCX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 9373449.00
MDCX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -383823.00
MDCX balance_sheet (quarterly, 2025-09-30) — Other Properties: 196249.00
MDCX income_statement (quarterly, 2025-09-30) — Other Special Charges: 182721.00
MDCX balance_sheet (quarterly, 2025-09-30) — Payables: 2170589.00
MDCX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3433716.00
MDCX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 297303.00
MDCX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 728379.00
MDCX income_statement (quarterly, 2025-09-30) — Pretax Income: -15981312.00
MDCX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 3914400.00
MDCX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -5719853.00
MDCX income_statement (quarterly, 2025-09-30) — Research And Development: 10402258.00
MDCX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -56163630.00
MDCX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1424215.00
MDCX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5024082.00
MDCX balance_sheet (quarterly, 2025-09-30) — Share Issued: 20971122.00
MDCX income_statement (quarterly, 2025-09-30) — Special Income Charges: -182721.00
MDCX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 852757.00
MDCX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -910126.00
MDCX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -910126.00
MDCX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MDCX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Assets: 9977661.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -880664.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Debt: 7051532.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -804890.00
MDCX income_statement (quarterly, 2025-09-30) — Total Expenses: 15426340.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 10782551.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 196249.00
MDCX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 124650.00
MDCX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -15426340.00
MDCX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -182721.00
MDCX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -182721.00
MDCX balance_sheet (quarterly, 2025-09-30) — Working Capital: -876489.00
MDCX income_statement (annual, 2025-12-31) — +Operating Expense: 34359302.00
MDCX income_statement (quarterly, 2025-12-31) — +Operating Expense: 7790600.00
MDCX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
MDCX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
MDCX balance_sheet (annual, 2025-12-31) — Accounts Payable: 3435297.00
MDCX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3435297.00
MDCX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 6879575.00
MDCX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 6879575.00
MDCX income_statement (annual, 2025-12-31) — Basic Average Shares: 17283824.00
MDCX income_statement (annual, 2025-12-31) — Basic EPS: -2.74
MDCX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 4164323.00
MDCX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8662091.00
MDCX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 205595.00
MDCX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 205595.00
MDCX balance_sheet (annual, 2025-12-31) — Capital Stock: 57390109.00
MDCX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 57390109.00
MDCX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8705218.00
MDCX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8705218.00
MDCX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8705218.00
MDCX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8705218.00
MDCX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 31939785.00
MDCX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 6653470.00
MDCX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4619152.00
MDCX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MDCX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -22776769.00
MDCX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6609115.00
MDCX cash_flow (annual, 2025-12-31) — Change In Account Payable: 923552.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1303585.00
MDCX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -438802.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -549969.00
MDCX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -142612.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -36441.00
MDCX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -99305.00
MDCX cash_flow (annual, 2025-12-31) — Change In Payable: 897569.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Payable: 1276981.00
MDCX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 458767.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 727012.00
MDCX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 352825.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 35303.00
MDCX cash_flow (annual, 2025-12-31) — Change In Working Capital: 569675.00
MDCX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 626569.00
MDCX cash_flow (annual, 2025-12-31) — Changes In Cash: 4543864.00
MDCX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 44355.00
MDCX balance_sheet (annual, 2025-12-31) — Common Stock: 57390109.00
MDCX balance_sheet (quarterly, 2025-12-31) — Common Stock: 57390109.00
MDCX balance_sheet (annual, 2025-12-31) — Common Stock Equity: -67554.00
MDCX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -67554.00
MDCX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 18217431.00
MDCX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 3330411.00
MDCX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 695109.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 695109.00
MDCX balance_sheet (annual, 2025-12-31) — Current Assets: 9890644.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Assets: 9890644.00
MDCX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 145456.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 145456.00
MDCX balance_sheet (annual, 2025-12-31) — Current Debt: 5245543.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Debt: 5245543.00
MDCX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5390999.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5390999.00
MDCX balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 99305.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 99305.00
MDCX balance_sheet (annual, 2025-12-31) — Current Liabilities: 9938062.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9938062.00
MDCX balance_sheet (annual, 2025-12-31) — Current Notes Payable: 5245543.00
MDCX balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 5245543.00
MDCX income_statement (annual, 2025-12-31) — Diluted Average Shares: 17283824.00
MDCX income_statement (annual, 2025-12-31) — Diluted EPS: -2.74
MDCX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -47281513.00
MDCX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -20021709.00
MDCX balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 116476.00
MDCX balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 116476.00
MDCX income_statement (annual, 2025-12-31) — EBIT: -34359302.00
MDCX income_statement (quarterly, 2025-12-31) — EBIT: -7790600.00
MDCX income_statement (annual, 2025-12-31) — EBITDA: -34359302.00
MDCX income_statement (quarterly, 2025-12-31) — EBITDA: -7790600.00
MDCX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -2969.00
MDCX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1228.00
MDCX cash_flow (annual, 2025-12-31) — End Cash Position: 8705218.00
MDCX cash_flow (quarterly, 2025-12-31) — End Cash Position: 8705218.00
MDCX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 31939785.00
MDCX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 6653470.00
MDCX cash_flow (annual, 2025-12-31) — Free Cash Flow: -22776769.00
MDCX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -6609115.00
MDCX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -583823.00
MDCX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 10880.00
MDCX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 10880.00
MDCX income_statement (annual, 2025-12-31) — General And Administrative Expense: 17920391.00
MDCX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5199725.00
MDCX balance_sheet (annual, 2025-12-31) — Gross PPE: 170733.00
MDCX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 170733.00
MDCX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 221663.00
MDCX balance_sheet (annual, 2025-12-31) — Invested Capital: 5203854.00
MDCX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 5203854.00
MDCX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4619152.00
MDCX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00